the firm's post-grant practitioners are some of the most experienced in the country.

Surinder  Sachar
Richard D. Kelly
Johnny  Ma
Craig R. Feinberg
J. Derek  Mason, Ph.D., CLP
Andrew M. Ollis
Sameer  Gokhale
Christopher  Ricciuti
Nanlin  Wang, Ph.D.
Yorikatsu  Hohokabe, Ph.D.
Dale M. Shaw
Yin Y. Nelson, Ph.D.
Aristotelis M. Psitos
Jianping (James)  Wu
Eckhard H. Kuesters
Alexander B. Englehart
Yanwen  Fei
Nicholas  Rosa, Ph.D.
Jenchieh (Joseph) Yuan
Norman F. Oblon
Chika (Teranishi) Iitoyo
Diane  Jones
Tao  Feng, Ph.D.
Kevin M. McKinley
Carl E. Schlier
Robert  Tarcu
Marina I. Miller, Ph.D.
David M. Longo, Ph.D.
Frank J. West
Long  Phan, Ph.D.
Jeffrey B. McIntyre
Akihiro  Yamazaki
Elissa L. Sanford
Yuki  Onoe
Edwin D. Garlepp
Anna Z. Lloyd
Thomas M. Cunningham, Ph.D.
John S. Kern
Brian B. Darville
John F. Presper
Ching-Cheng (Tony)  Chang
Bogdan A. Zinchenko
Philippe J.C. Signore, Ph.D.
Kevin Ross  Davis
Teddy S. Gron
Arthur I. Neustadt
Robert W. Downs
Steven B. Chang
Tia D. Fenton
Alec M. Royka
Stephen G. Baxter, Ph.D.
Kevin L. Hartman, Ph.D.
Charles L. Gholz
Peifang  Tian, Ph.D.
Daniel J. Pereira, Ph.D.
John  Sipos
Grace E. Kim
Colin B. Harris
Derek  Lightner, Ph.D.
Michael R. Casey, Ph.D.
James R. Love
Robert T. Pous
Jay E. Rowe, Jr., Ph.D.
Vincent K. Shier, Ph.D.
Erik M. Stang, Ph.D.
Yuanyi (Alex) Zhang, Ph.D.
Christopher I. Donahue
Stefan Uwe  Koschmieder, Ph.D.
Eric W. Schweibenz
Kurt M. Berger, Ph.D.
Ryan W. Smith
Kasumi  Kanetaka
Aldo  Martinez


Artificial Intelligence (AI)
Artificial Intelligence (AI)
Digital Health
Digital Health
Energy & Renewables
Energy & Renewables

Fast Facts

About Our

Law Firm

About Our Law Firm

Headquartered within steps of the USPTO with an affiliate office in Tokyo, Oblon is one of the largest law firms in the United States focused exclusively on intellectual property law.

Get to know our


Get to know our History

Norman Oblon with Stanley Fisher and Marvin Spivak launched what was to become Oblon, McClelland, Maier & Neustadt, LLP, one of the nation's leading full-service intellectual property law firms.

Our Local and

Global Reach

Our Local and Global Reach

Outside the US, we service companies based in Japan, France, Germany, Italy, Saudi Arabia, and farther corners of the world. Our culturally aware attorneys speak many languages, including Japanese, French, German, Mandarin, Korean, Russian, Arabic, Farsi, Chinese.

A few of our


A few of our ACCOLADES

Oblon's professionals provide industry-leading IP legal services to many of the world's most admired innovators and brands.




From the minute you walk through our doors, you'll become a valuable part of a team that fosters a culture of innovation, client service and collegiality.

A few ways to

GET In Touch

A few ways to GET In Touch
US Office

Telephone: 703-413-3000
Learn More +

Tokyo Office

Telephone: +81-3-6212-0550
Learn More +


Patent Forms

Downloadable Patent Forms

The United States Patent and Trademark Office (USPTO) issued final rules implementing the inventor's oath or declaration provisions of the America Invents Act (AIA) on August 14, 2012.

USPTO Announces COVID-19 Deferred-Fee Provisional Patent Application Pilot Program

  • September 16, 2020
  • Firm News

On Wednesday, September 16, 2020, the USPTO issued a release stating:

The United States Patent and Trademark Office (USPTO) today announced a collaborative deferred-fee provisional patent application pilot program for inventions that combat COVID-19.  

The USPTO recognizes that its mission to issue high-quality patents to inventors goes hand-in-hand with dissemination of important scientific information to the public to promote further innovation. This information flow is now more important than ever in view of the urgent challenges posed by the COVID-19 outbreak. Under the pilot program, applicants may defer payment of the provisional application filing fee until the filing of a corresponding, non-provisional application. To foster dissemination and collaboration, they must agree that the technical subject matter disclosed in their provisional applications will be available to the public on the USPTO’s website. By making their disclosures available, applicants can contribute to the public in the fight against COVID-19 while protecting their patent rights. 

To qualify for the program, the subject matter disclosed in the provisional application must concern a product or process related to COVID-19, and such product or process must require Food and Drug Administration (FDA) approval for COVID-19 use, whether such approval has been obtained, is pending, or will be sought prior to marketing the subject matter for COVID-19.

The program is scheduled to accept applications for 12 months beginning on September 17, 2020. For more information on the deferred-fee provisional patent application pilot program, please read the full notice.

Relatedly, and further to our April 28, 2020 post, Oblon is proud to still be currently waiving our fee for filing a provisional application for an invention directly related to addressing the COVID-19 pandemic.

Please contact us if you have any questions regarding this item.